Safety, Tolerability, and Pharmacokinetics of AB-836 in Healthy Subjects and Subjects With Chronic HBV Infection
Clinical trial NCT04775797 · TERMINATED
Trial details
- NCT number
- NCT04775797
- Sponsor
- Arbutus Biopharma Corporation
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-25
- Primary completion
- 2022-11-17
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.